Substance Use Disorders and ADHD

CNS Spectrums ◽  
2009 ◽  
Vol 14 (S6) ◽  
pp. 10-12 ◽  
Author(s):  
Oscar Bukstein
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Treatment Planning ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Attention Deficit ◽  
Psychiatric Comorbidity ◽  
Stimulant Medication ◽  
Medication Management ◽  
Hyperactivity Disorder

In examining the challenges in treating comorbid attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD), there are a number of issues regarding misinformation and misconception that exist for clinicians. Like other ADHD comorbidities, there is a lack of screening, particularly among adult clinical populations who have the psychiatric comorbidity or, for patients with SUDs, there is the issue of prioritization, which condition to treat first, and determining the place of medication management—particularly stimulant medication—paramount in treatment planning.

Treating adult ADHD and comorbid substance-related disorders

2016 ◽  
Vol 33 (S1) ◽  
pp. S54-S54
Author(s):  
J.A. Ramos-Quiroga
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Substance Use Disorders ◽  
Attention Deficit ◽  
Adult Adhd ◽  
Stimulant Medication ◽  
Behavioral Therapy ◽  
Neurodevelopmental Disorder ◽  
Hyperactivity Disorder ◽  
Competing Interest

Attention-deficit/hyperactivity disorder (ADHD) is a complex, and multifactorial and chronic neurodevelopmental disorder. Comorbid psychiatric disorders are highly prevalent in individuals with a diagnosis of ADHD. There is a solid overlap between ADHD and substance use disorders (SUD). Prevalence of SUD is high among patients with ADHD, so that SUD are approximately double as common among individuals with ADHD than in general population, and individuals with SUD have much higher rates than expected of a comorbid ADHD. Studies shown that treatment during childhood of attention-deficit/hyperactivity disorder with stimulant medication neither protects nor increases the risk of later substance use disorders. Nevertheless, recent studies found that patients with ADHD and SUD can reduce ADHD symptoms and SUD with stimulants and cognitive-behavioral therapy. Treatment of ADHD in patients with SUD requires a comprehensive diagnostic assessment. It is recommendable to stabilize the addiction prior to treating the ADHD. In this talk, the recent literature for the treatment of adults with co-occurring ADHD and SUD will be reviewed.Disclosure of interestThe author has not supplied his declaration of competing interest.

scholarly journals Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study

Addiction ◽  
2013 ◽  
Vol 109 (2) ◽  
pp. 262-272 ◽  
Author(s):  
Katelijne van Emmerik-van Oortmerssen ◽  
Geurt van de Glind ◽  
Maarten W. J. Koeter ◽  
Steve Allsop ◽  
Marc Auriacombe ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Substance Use Disorder ◽  
Attention Deficit ◽  
Psychiatric Comorbidity ◽  
Treatment Seeking ◽  
Hyperactivity Disorder

scholarly journals ADHD with comorbid substance use disorder: review of treatment

2012 ◽  
Vol 18 (6) ◽  
pp. 436-446 ◽  
Author(s):  
Rakesh Magon ◽  
Ulrich Müller
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Attention Deficit ◽  
Adult Adhd ◽  
Treatment Algorithm ◽  
Hyperactivity Disorder ◽  
The Relationship ◽  
Illicit Substances

SummarySubstance use disorders are a frequent comorbidity in adult attention-deficit hyperactivity disorder (ADHD). This review discusses the relationship between adult ADHD and substance use disorder, including use of licit and illicit substances such as nicotine, alcohol, cocaine and cannabis. We discuss treatment studies in this area and provide a treatment algorithm to guide clinicians in the management of adult ADHD comorbid with different forms and severities of substance use disorder.

Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity

2020 ◽  
Vol 26 (Suppl. 4-5) ◽  
pp. 179-190
Author(s):  
María C. Vélez-Pastrana ◽  
Rafael A. González ◽  
Alexandra Ramos-Fernández ◽  
Rafael R. Ramírez Padilla ◽  
Frances R. Levin ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Substance Use Disorder ◽  
Attention Deficit ◽  
Psychiatric Comorbidity ◽  
Hyperactivity Disorder

scholarly journals Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder

2013 ◽  
Vol 203 (2) ◽  
pp. 112-119 ◽  
Author(s):  
Annabeth P. Groenman ◽  
Jaap Oosterlaan ◽  
Nanda N. J. Rommelse ◽  
Barbara Franke ◽  
Corina U. Greven ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Conduct Disorder ◽  
Nicotine Dependence ◽  
Substance Use Disorders ◽  
Substance Use Disorder ◽  
Attention Deficit ◽  
Stimulant Treatment ◽  
Hyperactivity Disorder ◽  
Oppositional Defiant

BackgroundAttention-deficit hyperactivity disorder (ADHD) is linked to increased risk for substance use disorders and nicotine dependence.AimsTo examine the effects of stimulant treatment on subsequent risk for substance use disorder and nicotine dependence in a prospective longitudinal ADHD case–control study.MethodAt baseline we assessed ADHD, conduct disorder and oppositional defiant disorder. Substance use disorders, nicotine dependence and stimulant treatment were assessed retrospectively after a mean follow-up of 4.4 years, at a mean age of 16.4 years.ResultsStimulant treatment of ADHD was linked to a reduced risk for substance use disorders compared with no stimulant treatment, even after controlling for conduct disorder and oppositional defiant disorder (hazard ratio (HR) = 1.91, 95% Cl 1.10−3.36), but not to nicotine dependence (HR = 1.12, 95% Cl 0.45−2.96). Within the stimulant-treated group, a protective effect of age at first stimulant use on substance use disorder development was found, which diminished with age, and seemed to reverse around the age of 18.ConclusionsStimulant treatment appears to lower the risk of developing substance use disorders and does not have an impact on the development of nicotine dependence in adolescents with ADHD.

Sign in / Sign up

Export Citation Format

Share Document